Phase I-II PTCy, Bortezomib and Sitagliptin for Prevention of GvHD Following Allogeneic HSCT

Clinical trial NCT07675174 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07675174
Sponsor: Northwell Health
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

GVHD - Graft-Versus-Host Disease

Start date: 2026-07-01
Primary completion: 2030-07-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.